DKA

Reading File
Finding Sources
Searching PubMed

"diabetic ketoacidosis" management

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Now I have comprehensive data from two major textbooks. Let me compile the full answer.

Diabetic Ketoacidosis (DKA)


Definition

DKA is defined by a triad of three fundamental biochemical abnormalities:
  1. Hyperglycemia (glucose typically >250 mg/dL, though can be variable)
  2. Ketonemia/ketonuria (urine ketones 2+ or more, or serum ketones ≥3.0 mmol/L)
  3. Metabolic acidosis (arterial or venous pH <7.3, serum HCO₃ <18 mmol/L)
  • Goldman-Cecil Medicine, p. 2483

Pathophysiology

The core problem is insulin deficiency + counter-regulatory hormone excess (glucagon, cortisol, catecholamines, growth hormone):
AxisMechanismConsequence
CarbohydrateDecreased glucose uptake, increased gluconeogenesisHyperglycemia
FatHormone-sensitive lipase activated → ↑ free fatty acids → hepatic ketogenesis (β-hydroxybutyrate, acetoacetate, acetone)Ketoacidosis
ProteinAccelerated proteolysis, ↑ amino acids to liverFurther gluconeogenesis
RenalOsmotic diuresis from glycosuriaDehydration, electrolyte loss
RespiratoryKussmaul breathing to compensate acidosisLowers pCO₂, consumes bicarbonate
Glucose and ketones are released into the circulation faster than they are utilized. The resulting osmotic diuresis causes profound dehydration (typically 3-5 L fluid deficit in adults, sometimes up to 10 L in severe cases), with losses of sodium (5-10 mmol/kg), potassium (5-7 mmol/kg), phosphorus, and magnesium.
  • Rosen's Emergency Medicine, p. 2542-2543
  • Goldman-Cecil Medicine, p. 2483-2484

Precipitants

Most common:
  • Infections (especially pneumonia, UTI)
  • Inadequate insulin / non-adherence
  • New-onset type 1 diabetes (~25% of DKA episodes)
  • Acute coronary syndrome
Other precipitants:
  • Cerebrovascular accident, pulmonary embolism, pancreatitis
  • Drugs: corticosteroids, SGLT-2 inhibitors, clozapine, olanzapine, cocaine, sympathomimetics, thiazides
  • Endocrinopathies: Cushing syndrome, thyrotoxicosis, acromegaly
  • Burns, hyperthermia/hypothermia

Clinical Features

Symptoms (typically evolve over hours to days):
  • Polyuria, polydipsia, polyphagia
  • Weakness, lethargy, weight loss
  • Nausea, vomiting, anorexia
  • Abdominal pain (~50% of patients, especially children - usually resolves with treatment; in adults, more likely to represent a true abdominal precipitant)
Signs:
  • Kussmaul breathing - deep, rapid respirations to compensate acidosis
  • Fruity/acetone breath
  • Tachycardia, orthostatic hypotension or frank hypotension
  • Dry skin and mucous membranes (dehydration)
  • Depressed sensorium - degree correlates with osmolality
  • Elevated temperature usually signals infection (DKA itself rarely causes fever)

Diagnosis & Lab Findings

ParameterTypical Finding
Glucose>350 mg/dL (DKA); can be normal in euglycemic DKA (e.g., SGLT-2i)
pH<7.3 (mild: 7.20-7.30; severe: <7.00)
HCO₃<18 mmol/L
Anion gapElevated (proportional to HCO₃ drop)
Ketones↑↑ (β-hydroxybutyrate preferred)
SodiumOften low (dilutional + osmotic shift); correct for glucose: add 1.6 mEq/L per 100 mg/dL glucose above normal
PotassiumNormal or HIGH initially (acidosis shifts K⁺ extracellularly), but total body K⁺ is depleted - correct: subtract 0.6 mEq/L per 0.1 pH decrease
WBCElevated (reflects ketosis severity, not necessarily infection; only band neutrophilia indicates infection)
CreatinineMay be falsely elevated on autoanalyzer
LipasePreferred over amylase if pancreatitis suspected (must be >3x ULN for diagnosis)
HematocritElevated (hemoconcentration)
Key pitfall: The serum K⁺ may appear normal or high at presentation but will drop sharply once insulin is started. Never begin insulin if K⁺ <3.3 mEq/L - replace first.

Severity Classification

MildModerateSevere
Glucose (mg/dL)>250>250>250
pH7.25-7.307.00-7.24<7.00
HCO₃ (mEq/L)15-1810-14<10
Anion gap>10>12>12
Mental statusAlertAlert/drowsyStupor/coma

Treatment

1. Fluids (Priority #1)

  • Adult: 1-2 L of 0.9% NS IV over 1-3 hours initially; then 250-500 mL/hr depending on fluid deficit. Total replacement typically 2-4 L in first 2-4 hours.
  • Children: 20 mL/kg NS over the first hour.
  • Switch to 0.45% NS once glucose falls to ~250-300 mg/dL; add dextrose (D5W + 0.45% NS) to prevent hypoglycemia while insulin continues.
  • Avoid large amounts of normal saline (hyperchloremic acidosis risk).

2. Potassium

  • If K⁺ <3.3 mEq/L: Hold insulin, replace K⁺ aggressively (IV, 20-40 mEq/hr) until ≥3.3 mEq/L
  • If K⁺ 3.3-5.5 mEq/L: Add 20-40 mEq KCl per liter of fluid
  • If K⁺ >5.5 mEq/L: Hold K⁺ supplementation, recheck every 2 hours

3. Insulin

  • Do NOT start insulin until K⁺ ≥3.3 mEq/L
  • Continuous IV regular insulin at 0.1 units/kg/hour
  • When glucose drops to 250-300 mg/dL AND ketones <1.0 mmol/L: reduce to 0.05 units/kg/hour to prevent hypoglycemia
  • In HHS: start IV fluid first; only add insulin when glucose stops falling on fluids alone

4. Other Electrolytes

  • Phosphorus: Routine replacement generally not necessary
  • Magnesium: Correct with 1-2 g MgSO₄ if low (serum levels may underestimate deficit)

5. Bicarbonate

  • Routine bicarbonate use is NOT recommended
  • May consider if pH <6.9 with severe hemodynamic compromise
  • Correct the underlying cause (fluids + insulin) - bicarbonate corrects as ketones clear

6. Identify and Treat Precipitant

  • Blood cultures, urine culture, CXR if infection suspected
  • ECG (acute MI as precipitant)
  • Look for occult sepsis, PE, pancreatitis

7. Monitoring

Meticulous flow sheets tracking:
  • Vital signs, fluid I&O (hourly urine output)
  • Serum glucose (hourly initially)
  • Electrolytes, BUN/Cr, pH, HCO₃ every 2-4 hours
  • Ketones (β-hydroxybutyrate or urine ketones)

8. Transition to Subcutaneous Insulin

  • DKA is resolved when: glucose <200 mg/dL, pH >7.3, HCO₃ >18 mEq/L, anion gap normalized
  • Overlap IV insulin with first SC dose by 1-2 hours before discontinuing IV to prevent rebound

Special Considerations

Euglycemic DKA: Can occur with SGLT-2 inhibitors (glucose may be <200 mg/dL). Clinical suspicion is key.
Intubation in DKA: Avoid if at all possible - patients have enormous respiratory drive. If intubated (e.g., comatose + vomiting), maintain hyperventilation or acidosis will worsen precipitously.
Cerebral edema: Major complication, mainly in children. Risk increased with rapid osmotic shifts. Symptoms: headache, deteriorating mental status after initial improvement.
Pregnancy: DKA can occur at lower glucose levels and is associated with high fetal mortality. Aggressive management required.

Prognosis

Mortality for DKA remains approximately 4% despite treatment - higher at extremes of age and with severe precipitating illness. HHS mortality is substantially higher (~20%).
  • Goldman-Cecil Medicine, p. 2484
  • Rosen's Emergency Medicine, p. 2542-2544

Recent Evidence (2024-2026)

Two recent meta-analyses are relevant to management:
These suggest evolving practice toward subcutaneous insulin protocols, though IV infusion remains standard in moderate-severe DKA.
This is a shared conversation. Sign in to Orris to start your own chat.